Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
- PMID: 30406413
- DOI: 10.1007/s00213-018-5085-3
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
Abstract
Background: Research suggests that mindfulness-based interventions may improve mindfulness-related capacities (e.g., decentering, non-judging, and non-reacting) and emotion regulation. Previously, our group reported that ayahuasca could be a potential analogue of mindfulness practice. The main aim of the current study was to examine the effects of ayahuasca on emotional regulation and mindfulness-related capacities. Secondarily, we sought to explore the effects of ayahuasca on individuals with borderline personality disorder (BPD) traits.
Method: This is an observational study of 45 volunteers who participated in an ayahuasca session. The volunteers completed various self-report instruments designed to measure emotional dysregulation (Difficulties in Emotion Regulation Scale (DERS)) and mindfulness traits (Five Facet Mindfulness Questionnaire (FFMQ)-Short Form and Experiences Questionnaire (EQ)) prior to and 24 h after the ayahuasca session. The volunteers were divided into two subgroups based on their score on the McLean Screening Instrument for BPD (MSI-BPD). Twelve participants were grouped into the BPD-like traits subgroup while the rest of them were included in the non-BPD-like subgroup. We performed within-subjects and between-group analyses.
Results: Overall, the participants showed significant improvements on the FFMQ subscales observing, acting with awareness, non-judging, and non-reacting and also significantly improved on decentering (EQ scale) and on the DERS subscales emotional non-acceptance, emotional interference, and lack of control. The BPD-like subgroup also showed significant improvements on the DERS subscales emotional interference and lack of control but not in mindfulness capacities.
Conclusions: These findings suggest a potential therapeutic effect for ayahuasca in emotion regulation and mindfulness capacities (including decentering, acceptance, awareness, and sensitivity to meditation practice). Based on these results, we believe that ayahuasca therapy could be of value in clinical populations, such as individuals with BPD, affected by emotion dysregulation.
Keywords: Ayahuasca; Borderline personality disorder; Emotional dysregulation; Mindfulness.
Similar articles
-
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.Psychopharmacology (Berl). 2016 Mar;233(5):823-9. doi: 10.1007/s00213-015-4162-0. Epub 2015 Nov 27. Psychopharmacology (Berl). 2016. PMID: 26612618
-
Ayahuasca may help to improve self-compassion and self-criticism capacities.Hum Psychopharmacol. 2022 Jan;37(1):e2807. doi: 10.1002/hup.2807. Epub 2021 Aug 19. Hum Psychopharmacol. 2022. PMID: 34411343
-
Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.Front Pharmacol. 2018 Mar 20;9:224. doi: 10.3389/fphar.2018.00224. eCollection 2018. Front Pharmacol. 2018. PMID: 29615905 Free PMC article.
-
Difficulties in emotion regulation in bipolar disorder: A systematic review and meta-analysis.J Affect Disord. 2022 Apr 1;302:352-360. doi: 10.1016/j.jad.2022.01.102. Epub 2022 Jan 29. J Affect Disord. 2022. PMID: 35093412
-
Mindfulness training for borderline personality disorder: A systematic review of contemporary literature.Personal Ment Health. 2022 Aug;16(3):180-189. doi: 10.1002/pmh.1529. Epub 2021 Sep 22. Personal Ment Health. 2022. PMID: 34553512
Cited by
-
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey.PLOS Glob Public Health. 2022 Nov 16;2(11):e0000438. doi: 10.1371/journal.pgph.0000438. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962494 Free PMC article.
-
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.Biomolecules. 2022 Nov 2;12(11):1618. doi: 10.3390/biom12111618. Biomolecules. 2022. PMID: 36358968 Free PMC article. Review.
-
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities.CNS Drugs. 2023 Jun;37(6):489-497. doi: 10.1007/s40263-023-01015-6. Epub 2023 May 31. CNS Drugs. 2023. PMID: 37256484 Free PMC article. Review.
-
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.Psychopharmacology (Berl). 2021 Jul;238(7):1899-1910. doi: 10.1007/s00213-021-05817-8. Epub 2021 Mar 10. Psychopharmacology (Berl). 2021. PMID: 33694031 Free PMC article. Clinical Trial.
-
"Tobacco Is the Chief Medicinal Plant in My Work": Therapeutic Uses of Tobacco in Peruvian Amazonian Medicine Exemplified by the Work of a Maestro Tabaquero.Front Pharmacol. 2020 Oct 7;11:594591. doi: 10.3389/fphar.2020.594591. eCollection 2020. Front Pharmacol. 2020. PMID: 33117182 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources